FindMyKOL
Clinical trialNCT00017433TerminatedPhase 2Interventional

Arsenic Trioxide in Treating Patients With Multiple Myeloma

SponsorCTI BioPharmaMultiple Myeloma and Plasma Cell Neoplasm
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of arsenic trioxide in treating patients who have relapsed or refractory stage II or stage III multiple myeloma.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Scripps Clinic

    La Jolla, California, United States

  • Rocky Mountain Cancer Center

    Denver, Colorado, United States

  • Georgia Cancer Specialist

    Marietta, Georgia, United States

  • University of Illinois at Chicago

    Chicago, Illinois, United States

  • Cleveland Clinic Taussig Cancer Center

    Cleveland, Ohio, United States

  • Swedish Cancer Institute

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2001
Primary completion
31 Jan 2005
Completion
31 Jan 2005
Last update posted
6 Oct 2020
Registered enrollment
—
Registry id
NCT00017433

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.